Drug Profile
GRT 3983Y
Alternative Names: GRT3983YLatest Information Update: 25 Jun 2015
Price :
$50
*
At a glance
- Originator Grunenthal
- Class Analgesics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Nov 2009 Phase-II clinical trials in Pain in USA (PO)